133 related articles for article (PubMed ID: 38881902)
21. Nucleophosmin/B23 promotes endometrial cancer cell escape from macrophage phagocytosis by increasing CD24 expression.
Lin CY; Tsai CL; Chao A; Lee LY; Chen WC; Tang YH; Chao AS; Lai CH
J Mol Med (Berl); 2021 Aug; 99(8):1125-1137. PubMed ID: 33954835
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel single chain fragment variable antibody targeting CD24-expressing cancer cells.
Eyvazi S; Kazemi B; Bandehpour M; Dastmalchi S
Immunol Lett; 2017 Oct; 190():240-246. PubMed ID: 28866120
[TBL] [Abstract][Full Text] [Related]
23. Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas.
Salnikov AV; Bretz NP; Perne C; Hazin J; Keller S; Fogel M; Herr I; Schlange T; Moldenhauer G; Altevogt P
Br J Cancer; 2013 Apr; 108(7):1449-59. PubMed ID: 23511563
[TBL] [Abstract][Full Text] [Related]
24. Cluster of differentiation 24 monoclonal antibody induces apoptosis in the osteosarcoma cells.
Zhang YH; Wang ZY; Hao FY; Zhang L
Eur Rev Med Pharmacol Sci; 2014; 18(14):2038-41. PubMed ID: 25027344
[TBL] [Abstract][Full Text] [Related]
25. CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis.
Burgos-Ojeda D; Wu R; McLean K; Chen YC; Talpaz M; Yoon E; Cho KR; Buckanovich RJ
Mol Cancer Ther; 2015 Jul; 14(7):1717-27. PubMed ID: 25969154
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of CD24 suppresses bone metastasis of lung cancer.
Okabe H; Aoki K; Yogosawa S; Saito M; Marumo K; Yoshida K
Cancer Sci; 2018 Jan; 109(1):112-120. PubMed ID: 29095550
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells.
Hosonaga M; Arima Y; Sugihara E; Kohno N; Saya H
Cancer Sci; 2014 Jul; 105(7):779-87. PubMed ID: 24754246
[TBL] [Abstract][Full Text] [Related]
28. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer.
Smith SC; Oxford G; Wu Z; Nitz MD; Conaway M; Frierson HF; Hampton G; Theodorescu D
Cancer Res; 2006 Feb; 66(4):1917-22. PubMed ID: 16488989
[TBL] [Abstract][Full Text] [Related]
29. CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.
Sun H; Jia J; Wang X; Ma B; Di L; Song G; Ren J
Clin Transl Oncol; 2013 Jan; 15(1):46-54. PubMed ID: 22855175
[TBL] [Abstract][Full Text] [Related]
30. Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.
Zhu J; Nie S; Wu J; Lubman DM
J Proteome Res; 2013 Jun; 12(6):2791-804. PubMed ID: 23679566
[TBL] [Abstract][Full Text] [Related]
31. GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis.
Agarwal N; Dancik GM; Goodspeed A; Costello JC; Owens C; Duex JE; Theodorescu D
Cancer Res; 2016 Sep; 76(17):5175-85. PubMed ID: 27312530
[TBL] [Abstract][Full Text] [Related]
32. The CD24
Zhou Z; Li Y; Kuang M; Wang X; Jia Q; Cao J; Hu J; Wu S; Wang Z; Xiao J
EBioMedicine; 2020 Jan; 51():102598. PubMed ID: 31901872
[TBL] [Abstract][Full Text] [Related]
33. Role of CD24 in anoikis resistance of ovarian cancer cells.
Li YH; Sun X; Wang HB
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):390-396. PubMed ID: 26072079
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
[TBL] [Abstract][Full Text] [Related]
35. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.
Jaggupilli A; Elkord E
Clin Dev Immunol; 2012; 2012():708036. PubMed ID: 22693526
[TBL] [Abstract][Full Text] [Related]
36. ELF5 inhibits the proliferation and invasion of breast cancer cells by regulating CD24.
Qu X; Li Q; Tu S; Yang X; Wen W
Mol Biol Rep; 2021 Jun; 48(6):5023-5032. PubMed ID: 34146197
[TBL] [Abstract][Full Text] [Related]
37. Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy.
Shen W; Shi P; Dong Q; Zhou X; Chen C; Sui X; Tian W; Zhu X; Wang X; Jin S; Wu Y; Chen G; Qiu L; Zhai W; Gao Y
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344099
[TBL] [Abstract][Full Text] [Related]
38. PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer.
Chen K; Dai M; Luo Q; Wang Y; Shen W; Liao Y; Zhou Y; Cheng W
Int J Biochem Cell Biol; 2023 Feb; 155():106358. PubMed ID: 36584909
[TBL] [Abstract][Full Text] [Related]
39. CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.
Overdevest JB; Thomas S; Kristiansen G; Hansel DE; Smith SC; Theodorescu D
Cancer Res; 2011 Jun; 71(11):3802-11. PubMed ID: 21482678
[TBL] [Abstract][Full Text] [Related]
40. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
